02/21/2019 | Miguel Forte
We should be thrilled with the success of the approved CD-19 CAR-T therapies. But the field is still young, and we are only scratching the surface of what’s possible.
01/25/2019 | Jonathan James
Harvard Medical School’s Richard Sherwood digs into the potential and pitfalls of gene editing technology.
01/17/2019 | Jonathan James
How DNA origami nanostructures could find their way into the treatment of acute kidney injury.
01/16/2019 | Phoebe Harkin
Two chemical components; opposite effects. How medical marijuana impacts glaucoma for better – and for worse.
01/08/2019 | Jonathan James
We sat down with David Eidelberg shortly after the publication of his group’s most recent paper in Science Translational Medicine.
11/22/2018 | Stephanie Sutton
Sitting Down With… Danny Bar-Zohar, Global Head of Neuroscience Development at Novartis, Switzerland.
11/22/2018 | Roisin McGuigan
A new method for discovering antibiotics makes use of an unusual source of complex microbial communities: bear saliva.
09/24/2018 | Ruth Steer
Could activated T cells play a major role in driving neurodegeneration in glaucoma?
09/24/2018 | Sam Cobb
A promising candidate is on the verge of entering clinical development… What happens when you see an opportunity to make it even better?
09/20/2018 | Carlo Medici
For better diagnosis and monitoring of Alzheimer’s disease, as well as drug R&D, we need to move toward widespread use of MRI biomarker imaging, even if blood screening tests become a reality
09/20/2018
A simple yet accurate model could help streamline ROP screening
09/04/2018 | James Strachan
Regulators step in to stop stem cell clinics from marketing unproven therapies.
09/04/2018 | Paul Ursell
Introducing the easy-to-use system that offers patients lower risks of complications – regardless of surgeon experience
04/25/2016 | Contributed by Ocean Optics
You might be interested in our Sister Publications:
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register